High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

P. Vainio; L. Lehtinen; Mika Hilvo; T. Mirtti; John Mpindi; Pekka Kohonen; Vidal Fey; K. Ketola; K. Alanen; Merja Perälä; Matej Oresic; Olli Kallioniemi; Kristiina Iljin

High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

P. Vainio
, L. Lehtinen
, Mika Hilvo
, T. Mirtti
, John Mpindi
, Pekka Kohonen
, Vidal Fey
, K. Ketola
, K. Alanen
, Merja Perälä
, Matej Oresic
, Olli Kallioniemi
, Kristiina Iljin

BA6308 Health data analytics

VTT (former employee or external)
University of Turku
University of Helsinki
Turku University Hospital

Research output: Chapter in Book/Report/Conference proceeding › Conference abstract in proceedings › Scientific

Original language	English
Title of host publication	Metabolomics 2010 abstract book
Subtitle of host publication	Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery
Pages	135
Publication status	Published - 2010
MoE publication type	Not Eligible
Event	Metabolomics 2010: Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery - Amsterdam, Netherlands Duration: 27 Jun 2010 → 1 Jul 2010

Conference

Conference	Metabolomics 2010
Country/Territory	Netherlands
City	Amsterdam
Period	27/06/10 → 1/07/10

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

http://fiehnlab.ucdavis.edu/downloads/staff/kind/metabolomics_2010_abstract_book.pdf

Cite this

Vainio, P., Lehtinen, L., Hilvo, M., Mirtti, T., Mpindi, J., Kohonen, P., Fey, V., Ketola, K., Alanen, K., Perälä, M., Oresic, M., Kallioniemi, O., & Iljin, K. (2010). High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. In Metabolomics 2010 abstract book: Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery (pp. 135) http://fiehnlab.ucdavis.edu/downloads/staff/kind/metabolomics_2010_abstract_book.pdf

@inbook{92587b764c0442c0b36a51cfcf360e0e,

title = "High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers",

author = "P. Vainio and L. Lehtinen and Mika Hilvo and T. Mirtti and John Mpindi and Pekka Kohonen and Vidal Fey and K. Ketola and K. Alanen and Merja Per{\"a}l{\"a} and Matej Oresic and Olli Kallioniemi and Kristiina Iljin",

year = "2010",

language = "English",

pages = "135",

booktitle = "Metabolomics 2010 abstract book",

note = "Metabolomics 2010 : Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery ; Conference date: 27-06-2010 Through 01-07-2010",

}

Vainio, P, Lehtinen, L, Hilvo, M, Mirtti, T, Mpindi, J, Kohonen, P, Fey, V, Ketola, K, Alanen, K, Perälä, M, Oresic, M, Kallioniemi, O & Iljin, K 2010, High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. in Metabolomics 2010 abstract book: Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery. pp. 135, Metabolomics 2010, Amsterdam, Netherlands, 27/06/10. <http://fiehnlab.ucdavis.edu/downloads/staff/kind/metabolomics_2010_abstract_book.pdf>

High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers. / Vainio, P.; Lehtinen, L.; Hilvo, Mika et al.
Metabolomics 2010 abstract book: Breakthroughs in plant, microbial and human biology, clinical and nutritional research, and biomarker discovery. 2010. p. 135.

Research output: Chapter in Book/Report/Conference proceeding › Conference abstract in proceedings › Scientific

TY - CHAP

T1 - High-throughput screening for novel prostate cancer drug targets identifies PLA2G7 as a putative target for ERG oncogene positive cancers

AU - Vainio, P.

AU - Lehtinen, L.

AU - Hilvo, Mika

AU - Mirtti, T.

AU - Mpindi, John

AU - Kohonen, Pekka

AU - Fey, Vidal

AU - Ketola, K.

AU - Alanen, K.

AU - Perälä, Merja

AU - Oresic, Matej

AU - Kallioniemi, Olli

AU - Iljin, Kristiina

PY - 2010

Y1 - 2010

M3 - Conference abstract in proceedings

SP - 135

BT - Metabolomics 2010 abstract book

T2 - Metabolomics 2010

Y2 - 27 June 2010 through 1 July 2010

ER -